New data shows an experimental Alzheimer's drug modestly slowed the brain disease's inevitable worsening. health Alzheimers kprc2 click2houston
FILE - This Oct. 7, 2003 file photo shows a closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. An experimental Alzheimers drug modestly slowed the brain diseases inevitable worsening, researchers reported Tuesday, Nov. 29, 2022 - and the next question is how much difference that might make in peoples lives. Japanese drugmaker Eisai and its U.S.
Lecanemab delayed patients’ worsening by about five months over the course of the 18-month study, Eisai’s Dr. Michael Irizarry told The Associated Press. Also, lecanemab recipients were 31% less likely to advance to the next stage of the disease during the study.Every two weeks, study participants received intravenous lecanemab or a dummy infusion. Researchers tracked them using an 18-point scale that measures cognitive and functional ability.
“It is unlikely that the small difference reported in this trial will be noticeable by individual patients,” said Dr. Madhav Thambisetty of the National Institute on Aging, who noted he wasn’t speaking for the government agency. behind Alzheimer’s -- can delay disease progression, said Maria Carrillo, chief science officer for the Alzheimer’s Association.
Amyloid-targeting drugs can cause side effects that include swelling and bleeding in the brain, and lecanemab did as well. One type of this swelling was seen in about 13% of recipients. Eisai said most were mild or asymptomatic.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
New York City Mayor Announces New Effort to Tackle Homeless ‘Mental Health Crisis’New York City will begin hospitalizing homeless people who are severely mentally ill in an effort to move individuals off the streets to get the care they need
Consulte Mais informação »
Lancia Design Day heralds start of a new eraLancia is back! A new logo, a new philosophy and new cars coming, too. Hopefully they'll have wheels 🛞
Consulte Mais informação »
New Alzheimer’s drug shows promise in slowing disease but may contain significant risks, study showsAn experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers report — but it remains unclear how much difference that might make in people’s lives.
Consulte Mais informação »
DOJ: Bothell drug dealer sentenced 10 years for involvement in 2020 drug ring takedownA Bothell man who was involved in a major drug ring bust in 2020 was sentenced to 10 years in prison on Tuesday, according to the U.S. Department of Justice (DOJ). FOX13
Consulte Mais informação »
New Alzheimer’s Drug Shows Positive Results but Side EffectsA new Alzheimer’s drug slowed cognitive decline in a study, but caused brain bleeds and swelling in some patients, furthering debate about its usefulness
Consulte Mais informação »
New data shows Alzheimer's drug can slow cognitive declineResearchers followed nearly 1,800 patients over the course of 18 months and found the drug 'resulted in moderately less decline on measures of cognition and function,' compared to patients who received a placebo.
Consulte Mais informação »